MAPT and Alzheimer disease: Tau pathology in AD is caused by changes in signaling pathways such the mTOR, GSK-3β, CDK5, MAPKs, and SIRT1 pathways, which cumulatively influence tau phosphorylation, aggregation, and clearance.